CXCR1 and neoplasm: CAR-T cells expressing CXCR2 appeared more efficacious at tumor homing than CXCR1-expressing CAR-T cells, while also decreasing the tumor burden and increasing T-cell infiltration relative to CAR-T cells not expressing CXCR2 [186].